Cargando…
CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe
CVD 103-HgR live, attenuated oral cholera vaccine strain is indicated for single dose immunization against Vibrio cholerae, the causative agent for cholera. The vaccine packets containing buffer powder and lyophilized CVD 103-HgR are reconstituted in water and consumed. Studies were performed to exp...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222213/ https://www.ncbi.nlm.nih.gov/pubmed/34162914 http://dx.doi.org/10.1038/s41598-021-92182-3 |
_version_ | 1783711444815052800 |
---|---|
author | Duffin, R. Paul Delbuono, Michael Nishioka, Kylie Shabram, Paul Patel, Amish A. |
author_facet | Duffin, R. Paul Delbuono, Michael Nishioka, Kylie Shabram, Paul Patel, Amish A. |
author_sort | Duffin, R. Paul |
collection | PubMed |
description | CVD 103-HgR live, attenuated oral cholera vaccine strain is indicated for single dose immunization against Vibrio cholerae, the causative agent for cholera. The vaccine packets containing buffer powder and lyophilized CVD 103-HgR are reconstituted in water and consumed. Studies were performed to explore the viability of CVD 103-HgR in drinking waters from common sources. CVD 103-HgR vaccine was reconstituted in bottled and tap waters from the United States and Europe, and viability was measured via colony forming units assay. Chemical analysis of select water samples was used to identify chemicals that have a negative effect on CVD 103-HgR viability. CVD 103-HgR titers were stable in all bottled waters tested, including purified bottled water, bottled spring water, and sparkling waters. However, tap water from certain cities in the US and Europe affected viability and are not compatible with vaccine. Water chemistry revealed that these tap waters contained copper, likely leached from copper plumbing. These studies give high confidence in the stability of CVD 103-HgR reconstituted in a variety of bottled waters. Waters containing copper, including tap water, should not be used to reconstitute CVD 103-HgR strain oral vaccine due to the common use of copper plumbing. |
format | Online Article Text |
id | pubmed-8222213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-82222132021-06-24 CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe Duffin, R. Paul Delbuono, Michael Nishioka, Kylie Shabram, Paul Patel, Amish A. Sci Rep Article CVD 103-HgR live, attenuated oral cholera vaccine strain is indicated for single dose immunization against Vibrio cholerae, the causative agent for cholera. The vaccine packets containing buffer powder and lyophilized CVD 103-HgR are reconstituted in water and consumed. Studies were performed to explore the viability of CVD 103-HgR in drinking waters from common sources. CVD 103-HgR vaccine was reconstituted in bottled and tap waters from the United States and Europe, and viability was measured via colony forming units assay. Chemical analysis of select water samples was used to identify chemicals that have a negative effect on CVD 103-HgR viability. CVD 103-HgR titers were stable in all bottled waters tested, including purified bottled water, bottled spring water, and sparkling waters. However, tap water from certain cities in the US and Europe affected viability and are not compatible with vaccine. Water chemistry revealed that these tap waters contained copper, likely leached from copper plumbing. These studies give high confidence in the stability of CVD 103-HgR reconstituted in a variety of bottled waters. Waters containing copper, including tap water, should not be used to reconstitute CVD 103-HgR strain oral vaccine due to the common use of copper plumbing. Nature Publishing Group UK 2021-06-23 /pmc/articles/PMC8222213/ /pubmed/34162914 http://dx.doi.org/10.1038/s41598-021-92182-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Duffin, R. Paul Delbuono, Michael Nishioka, Kylie Shabram, Paul Patel, Amish A. CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe |
title | CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe |
title_full | CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe |
title_fullStr | CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe |
title_full_unstemmed | CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe |
title_short | CVD 103-HgR live, attenuated cholera vaccine strain viability in drinking waters from the US and Europe |
title_sort | cvd 103-hgr live, attenuated cholera vaccine strain viability in drinking waters from the us and europe |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222213/ https://www.ncbi.nlm.nih.gov/pubmed/34162914 http://dx.doi.org/10.1038/s41598-021-92182-3 |
work_keys_str_mv | AT duffinrpaul cvd103hgrliveattenuatedcholeravaccinestrainviabilityindrinkingwatersfromtheusandeurope AT delbuonomichael cvd103hgrliveattenuatedcholeravaccinestrainviabilityindrinkingwatersfromtheusandeurope AT nishiokakylie cvd103hgrliveattenuatedcholeravaccinestrainviabilityindrinkingwatersfromtheusandeurope AT shabrampaul cvd103hgrliveattenuatedcholeravaccinestrainviabilityindrinkingwatersfromtheusandeurope AT patelamisha cvd103hgrliveattenuatedcholeravaccinestrainviabilityindrinkingwatersfromtheusandeurope |